TROY is a promising prognostic biomarker in patients with colorectal cancer.
Nishioka M, Suehiro Y, Sakai K, Matsumoto T, Okayama N, Mizuno H, Ueno K, Suzuki N, Hashimoto S, Takami T, Hazama S, Nagano H, Sakaida I, Yamasaki T.
Nishioka M, et al. Among authors: hashimoto s.
Oncol Lett. 2018 Apr;15(4):5989-5994. doi: 10.3892/ol.2018.8079. Epub 2018 Feb 16.
Oncol Lett. 2018.
PMID: 29556315
Free PMC article.